PML induces a novel caspase-independent death process (original) (raw)
LaMorte, V.J., Dyck, J.A., Ochs, R.L. & Evans, R.M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl Acad. Sci. USA95, 4991– 4996 (1998). CASPubMed Google Scholar
Alcalay, M. et al. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol.18, 1084–1093 (1998). CASPubMedPubMed Central Google Scholar
Borden, K.L.B., Campbelldwyer, E.J., Carlile, G.W., Djavani, M. & Salvato, M.S. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J. Virol.72, 3819–3826 (1998). CASPubMedPubMed Central Google Scholar
Lamond, A.I. & Earnshaw, W.C. Structure and function in the nucleus. Science280, 547– 553 (1998). CASPubMed Google Scholar
Mu, Z.M., Chin, K.V., Liu, J.H., Lozano, G. & Chang, K.S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol.14, 6858– 6867 (1994). CASPubMedPubMed Central Google Scholar
Koken, M.H.M. et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene10, 1315– 1324 (1995). CASPubMed Google Scholar
Borden, K.L.B. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its ring domain. FEBS Lett.418, 30–34 (1997). CASPubMedPubMed Central Google Scholar
Le, X.-F., Vallian, S., Mu, Z.-M., Hung, M.-C. & Chang, K.-S. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene16, 1839– 1849 (1998). CASPubMed Google Scholar
Wang, Z.G. et al. Role of PML in cell growth and the retinoic acid pathway. Science279, 1547–1551 (1998). CAS Google Scholar
Stadler, M. et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene11, 2565–2573 (1995). CASPubMed Google Scholar
Gongora, C. et al. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem.272, 19457–19463 (1997). CASPubMed Google Scholar
Grötzinger, T., Jensen, K. & Will, H. The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-α activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem.271, 25253–25260 (1996). PubMed Google Scholar
Daniel, M.-T. et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood82, 1858– 1867 (1993). CASPubMed Google Scholar
Dyck, J.A. et al. A novel macromolecular structure is a target of the promyelocyte- retinoic acid receptor oncoprotein. Cell76, 333–343 (1994). CASPubMed Google Scholar
Koken, M.H.M. et al. The t(15;17) translocation alters a nuclear body in a RA-reversible fashion. EMBO J.13, 1073– 1083 (1994). CASPubMedPubMed Central Google Scholar
Weis, K. et al. Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocytic leukemia cells. Cell76, 345–356 (1994). CASPubMed Google Scholar
Grignani, F. et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature391, 815–818 (1998). CASPubMed Google Scholar
Lin, R.J. et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature391, 811– 814 (1998). CASPubMed Google Scholar
He, L.-Z. et al. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nature Genet.18, 126–135 (1998). CASPubMed Google Scholar
Quignon, F., Chen, Z. & de Thé, H., Retinoic acid and arsenic: towards oncogene targeted treatments of acute promyelocytic leukaemia. Biochim. Biophys. Acta1333, M53–M61 (1997). CASPubMed Google Scholar
Zhu, J. et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl Acad. Sci. USA94, 3978–3983 (1997). CASPubMed Google Scholar
Muller, S., Matunis, M.J. & Dejean, A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J.17, 61–70 (1998). CASPubMedPubMed Central Google Scholar
Jiang, W.Q. & Ringertz, N. Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence. Cell Growth Differentiation8, 513– 522 (1997). CASPubMed Google Scholar
Xiang, J., Chao, D.T. & Korsmeyer, S.J. BAX-induced cell death may not require interleukin 1 ß-converting enzyme-like proteases. Proc. Natl Acad. Sci. USA93, 14559–14563 (1996). CASPubMed Google Scholar
de Maria, R. et al. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science277, 1652– 1655 (1997). CASPubMed Google Scholar
Miller, T.M. et al. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell. Biol.139, 205–217 (1997). CASPubMedPubMed Central Google Scholar
McCarthy, N.J., Whyte, M.K., Gilbert, C.S. & Evan, G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell. Biol.136, 215–227 (1997). CASPubMedPubMed Central Google Scholar
Pastorino, J.G., Chen, S.-T., Tafani, M., Snyder, J.W. & Farber, J.L. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem.273, 7770–7775 (1998). CASPubMed Google Scholar
Wolter, K.G. et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol.139, 1281– 1292 (1997). CASPubMedPubMed Central Google Scholar
Hsu, Y.T., Wolter, K.G. & Youle, R.J. Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc. Natl Acad. Sci. USA94, 3668–3672 (1997). CASPubMed Google Scholar
Mandal, M., Adam, L., Mendelsohn, J. & Kumar, R. Nuclear targeting of bax during apoptosis in human colorectal cancer cells. Oncogene17, 999–1007 (1998). CASPubMed Google Scholar
Woo, M. et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev.12, 806–819 (1998). CASPubMedPubMed Central Google Scholar
Lavoie, J.N., Nguyen, M., Marcellus, R.C., Branton, P.E. & Shore, G.C. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell Biol.140, 637– 645 (1998). CASPubMedPubMed Central Google Scholar
Monney, L. et al. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J. Biol. Chem.273, 6121–6131 (1998). CASPubMed Google Scholar
Stuurman, N., Floore, A., Middelkoop, E., van Driel, R. & de Jong, L. PML shuttles between nuclear bodies and the cytoplasm. Cell. Mol. Biol. Letters2, 137–150 (1997). CAS Google Scholar
Koken, M.H.M. et al. Leukemia-associated retinoic acid receptor a fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Natl Acad. Sci. USA94, 10255– 10260 (1997). CAS Google Scholar
Okura, T. et al. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol.57, 4277–4281 (1996). Google Scholar
Wang, Z.G. et al. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell-lines and function in a PML and PML/RARα independent manner. Blood92, 1497– 1504. (1998). CASPubMed Google Scholar
Chan, J.Y.H. et al. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. Biochem. Biophys. Res. Comm.240, 640–646 (1997). CASPubMed Google Scholar
Wang, Z.-G. et al. Pml is essential for multiple apoptotic pathways. Nature Genet. 20, 266–272 (1998). CASPubMed Google Scholar
Han, J. et al. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev.10, 461–477 (1995). Google Scholar
Chelbi-Alix, M. & de Thé, H. Herpesvirus induced proteasome-dependent degradation of the nuclear body associated PML et Sp100 proteins. Oncogene, in press.
Everett, R. et al. The disruption of ND10 during herpes simplex virus infection correlates with the VmW110 and proteasome dependent loss of several PML isoforms. J. Virol.72, 6581–6591 (1998). CASPubMedPubMed Central Google Scholar
Grignani, F. et al. The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell74, 423–431 (1993). CASPubMed Google Scholar
Testa, U. et al. The PML/RARα fusion protein inhibits tumor necrosis factor induced apoptosis in U937 cells and acute promyelocytic leukemia blasts. J. Clin. Invest.101, 2278– 2289 (1998). CASPubMedPubMed Central Google Scholar
Chen, G.-Q. et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukaemia (APL): I. As2O 3 exerts dose-dependent dual effects on APL cells. Blood89, 3345–3353 (1997). CASPubMed Google Scholar
Gianni, M. et al. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic resistant NB4 cells. Blood91, 4300–4310 (1998). CASPubMed Google Scholar
Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med.187, 1477–1485 (1998). CASPubMedPubMed Central Google Scholar
Bazarbachi, A. et al. Arsenic trioxide and interferon α synergize to induce cell cycle arrest and apoptosis in HTLVI-transformed cells. Blood, in press.
Ameisen, J.C. The origin of programmed cell death. Science272, 1278–1279 (1996). CASPubMed Google Scholar
Green, D. & Reed, J. Mitochondria and apoptosis. Science281, 1309–1312 (1998). CASPubMed Google Scholar
de Thé, H. et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell66, 675–684 (1991). PubMed Google Scholar
Estaquier, J. & Ameisen, J.C. A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis. Blood90, 1618–1625 (1997). CASPubMed Google Scholar
Madani, A. et al. The 8 kD product of the putative oncogene MTCP-1 is a mitochondrial protein. Oncogene10, 2259– 2262 (1995). CASPubMed Google Scholar